International Patent: MUCOSA-BASED NON-INVASIVE GENE THERAPY WITH RECOMBINANT VECTOR

GENEVA, July 6 -- SUZHOU ROCROCK NO.1 BIOTECHNOLOGY CO., LTD. filed a patent application (CN2025/080921) for “MUCOSA-BASED NON-INVASIVE GENE THERAPY WITH RECOMBINANT VECTOR”. With publication no. WO/2026/137597, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/20

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....